M 720 3'-Azido 3'-deoxythymidine 5'-triphosphate, tetraammonium salt |
|
| (AZT-TP) | |
| Aqueous solution; 5 μmol/ml | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 575.30 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
M 720L 3'-Azido 3'-deoxythymidine 5'-triphosphate, tetralithium salt |
|
| (AZT-TP) | |
| Aqueous solution; 5 μmol/ml | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 575.30 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MG 105 3'-Azido 3'-deoxythymidine 5'-triphosphate, [thymine-2-13C-1,3-15N2, 99 atom % 13C, 99 atom % 15N]- |
|
| (AZT-TP, [thymine-2-13C-1,3-15N2, 99 atom % 13C, 99 atom % 15N]-) | |
| Solid | 1 μmol $980 |
| NextGen V-Vial - shipped on dry ice | 5 μmol $2485 |
| M.W. 510.2 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 720 3'-Azido-3'-deoxythymidine 5'-triphosphate, tetraammonium salt, [methyl-3H]- |
|
| (AZT-TP, [methyl-3H]-) | |
| Ethanol:water (1:1) solution | 250 μCi (9.25 MBq) $1970 |
| > 3 Ci(111 GBq)/mmol | 1 mCi (37 MBq) $3920 |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 575.3 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |